Principal Amount USD ($) | | | | | | Value |
| Medical Labs & Testing Services — 1.9% | |
1,393,750 | Charlotte Buyer, Inc., First Lien First Refinancing Term Loan, 10.076% (Term SOFR + 475 bps), 2/11/28 | $ 1,402,316 |
977,099 | eResearchTechnology, Inc., First Lien Tranche B-1 Term Loan, 9.344% (Term SOFR + 400 bps), 2/4/27 | 983,359 |
1,681,512 | FC Compassus LLC, Term B-1 Loan, 9.708% (Term SOFR + 425 bps), 12/31/26 | 1,642,627 |
174,431 | Icon Public Ltd. Co., Repriced Lux Term Loan, 7.335% (Term SOFR + 200 bps), 7/3/28 | 175,648 |
43,460 | Icon Public Ltd. Co., Repriced U.S. Term Loan, 7.335% (Term SOFR + 200 bps), 7/3/28 | 43,763 |
1,958,892 | Phoenix Guarantor Inc., First Lien Tranche B-4 Term Loan, 8.594% (Term SOFR + 325 bps), 2/21/31 | 1,961,341 |
967,588 | U.S. Anesthesia Partners, Inc., First Lien Initial Term Loan, 9.708% (Term SOFR + 425 bps), 10/1/28 | 937,178 |
| Total Medical Labs & Testing Services | $7,146,232 |
|
|
| Medical-Biomedical & Generation — 0.5% | |
1,944,091 | ANI Pharmaceuticals, Inc., Initial Term Loan, 11.458% (Term SOFR + 600 bps), 11/19/27 | $ 1,948,345 |
| Total Medical-Biomedical & Generation | $1,948,345 |
|
|
| Medical-Drugs — 2.0% | |
1,350,000 | Bausch Health Cos., Inc., Second Amendment Term Loan, 10.694% (Term SOFR + 525 bps), 2/1/27 | $ 1,260,562 |
475,000 | Endo Finance Holdings, Inc., Initial Term Loan, 9.783% (Term SOFR + 450 bps), 4/23/31 | 476,732 |
827,925 | Financiere Mendel, Additional Term USD Facility 1, 8.573% (Term SOFR + 325 bps), 11/12/30 | 832,065 |
1,591,532 | Jazz Pharmaceuticals, Inc., Term Loan B, 7.594% (Term SOFR + 225 bps), 5/5/28 | 1,596,079 |
2,114,718 | Organon & Co., 2024 Refinancing Dollar Term Loan, 7.835% (Term SOFR + 250 bps), 5/19/31 | 2,123,970 |
1,176,471 | Padagis LLC, Term B Loan, 10.326% (Term SOFR + 475 bps), 7/6/28 | 1,138,235 |
| Total Medical-Drugs | $7,427,643 |
|
|
| Medical-Generic Drugs — 0.6% | |
1,357,812 | Amneal Pharmaceuticals LLC, Initial Term Loan, 10.844% (Term SOFR + 550 bps), 5/4/28 | $ 1,371,390 |
736,875 | Perrigo Company Plc, Initial Term B Loan, 7.694% (Term SOFR + 225 bps), 4/20/29 | 737,059 |
| Total Medical-Generic Drugs | $2,108,449 |
|
|